Developmental and functional significance of the CSF-1 proteoglycan chondroitin sulfate chain

Blood

Volumn 107, Issue 2, 2006, Pages 786-795

  Nandi, Sayan ^b   Akhter, Mohammed P ^b   Seifert, Mark F ^b   Dai, Xu Ming ^b   Stanley, E Richard ^a  

^a ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CELL SURFACE PROTEIN; CHONDROITIN SULFATE GLYCOSAMINOGLYCAN; COLONY STIMULATING FACTOR 1; GLYCOPROTEIN; GLYCOSAMINOGLYCAN; ISOPROTEIN; MUTANT PROTEIN; PROTEIN PRECURSOR; PROTEOCHONDROITIN SULFATE; PROTEOGLYCAN; SECRETED GLYCOPROTEIN; UNCLASSIFIED DRUG;

ALBERS SCHOENBERG DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BIOACCUMULATION; BODY WEIGHT; CELL STRUCTURE; CONTROLLED STUDY; DEVELOPMENT; EYE DEVELOPMENT; EYELID; GROWTH RETARDATION; HEMATOPOIETIC TISSUE; IN VIVO STUDY; MACROPHAGE; MOLECULAR BIOLOGY; MOUSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SECRETION; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; STATISTICAL SIGNIFICANCE; TISSUE SPECIFICITY; TOOTH ERUPTION; TRANSGENE; TRANSGENIC MOUSE;

EID: 30444440914     PISSN: 00064971     EISSN: 00064971     Source Type: Journal    
DOI: 10.1182/blood-2005-05-1822     Document Type: Article

References (67)

1. Guilbert LJ, Stanley ER. Specific interaction of murine colony-stimulating factor with mono-nuclear phagocytic cells. J Cell Biol. 1980;85:153-159.
2. 125I-colony stimulating factor-1 with bone marrow-derived macrophages. J Biol Chem. 1986;261:4024-4032.
3. Sherr CJ, Rettenmeir CW, Sacca R, Roussel MF, Look AT, Stanley ER. The c-fms proto-oncogene product is related to the receptor for the mono-nuclear phagocyte growth factor, CSF-1. Cell. 1985;41:665-676.
4. Dai XM, Ryan GR, Hapel AJ, et al. Targeted disruption of the mouse colony-stimulating factor 1 receptor gene results in osteopetrosis, mono-nuclear phagocyte deficiency, increased primitive progenitor cell frequencies, and reproductive defects. Blood. 2002;99:111-120.
5. Stanley ER, Heard PM. Factors regulating macrophage production and growth: purification and some properties of the colony stimulating factor from medium conditioned by mouse L cells. J Biol Chem. 1977;252:4305-4312.
6. Rettenmier CW, Roussel MF. Differential processing of colony-stimulating factor 1 precursors encoded by two human cDNAs. Mol Cell Biol. 1988;8:5026-5034.
7. Manos MM. Expression and processing of a recombinant human macrophage colony-stimulating factor in mouse cells. Mol Cell Biol. 1988;8:5035-5039.
8. Price LKH, Choi HU, Rosenberg L, Stanley ER. The predominant form of secreted colony stimulating factor-1 is a proteoglycan. J Biol Chem. 1992;267:2190-2199.
9. Suzu S, Ohtsuki T, Yanai N, et al. Identification of a high molecular weight macrophage colonystimulating factor as a glycosaminoglycan-containing species. J Biol Chem. 1992;267:4345-4348.
10. Rettenmier CW, Roussel MF, Ashmun RA, Ralph P, Price K, Sherr CJ. Synthesis of membranebound colony-stimulating factor 1 (CSF-1) and downmodulation of CSF-1 receptors in NIH 3T3 cells transformed by cotransfection of the human CSF-1 and c-fms (CSF-1 receptor) genes. Mol Cell Biol. 1987;7:2378-2387.
11. Cosman D, Wignall J, Anderson D, et al. Human macrophage colony stimulating factor (M-CSF): alternate RNA splicing generates three different proteins that are expressed on the cell surface and secreted. Behring Inst Mitt. 1988:15-26.
12. Cerretti DP, Wignall J, Anderson D, Tushinski RJ, Gallis B, Cosman D. Membrane bound forms of human macrophage colony stimulating factor (MCSF, CSF-1). Prog Clin Biol Res. 1990;352:63-70.
13. Stein J, Borzillo GV, Rettenmier CW. Direct stimulation of cells expressing receptors for macrophage colony-stimulating factor (CSF-1) by a plasma membrane-bound precursor of human CSF-1. Blood. 1990;76:1308-1314.
14. Pixley FJ, Stanley ER. CSF-1 regulation of the wandering macrophage: complexity in action. Trends Cell Biol. 2004;14:628-638.
15. Roth P, Stanley ER. The biology of CSF-1 and its receptor. Curr Top Microbiol Immunol. 1992;181:141-167.
16. Cecchini MG, Dominguez MG, Mocci S, et al. Role of colony stimulating factor-1 in the establishment and regulation of tissue macrophages during postnatal development of the mouse. Development. 1994;120:1357-1372.
17. Dai XM, Zong XH, Sylvestre V, Stanley ER. Incomplete restoration of colony-stimulating factor 1 (CSF-1) function in CSF-1-deficient Csf1op/ Csf1op mice by transgenic expression of cell surface CSF-1. Blood. 2004;103:1114-1123.
18. Yoshida H, Hayashi S-I, Kunisada T, et al. The murine mutation "osteopetrosis" (op) is a mutation in the coding region of the macrophage colony stimulating factor (Csfm) gene. Nature. 1990;345:442-444.
19. Wiktor-Jedrzejczak W, Bartocci A, Ferrante AW Jr, et al. Total absence of colony-stimulating factor 1 in the macrophage-deficient osteopetrotic (op/op) mouse. Proc Natl Acad Sci U S A. 1990;87:4828-4832.
20. Felix R, Cecchini MG, Hofstetter W, Elford PR, Stutzer A, Fleisch H. Impairment of macrophage colony-stimulating factor production and lack of resident bone marrow macrophages in the osteopetrotic op/op mouse. J Bone Min Res. 1990;5:781-789.
21. Marks SC Jr, Lane PW. Osteopetrosis, a new recessive skeletal mutation on chromosome 12 of the mouse. J Hered. 1976;67:11-18.
22. Pollard JW, Stanley ER. Pleiotropic roles for CSF-1 in development defined by the mouse mutation osteopetrotic. Adv Dev Biochem. 1996;4:153-193.
23. Cohen PE, Nishimura K, Zhu L, Pollard JW. Macrophages: important accessory cells for reproductive function. J Leuk Biol. 1999;66:765-772.
24. Naito M, Hayashi S, Yoshida H, Nishikawa S, Shultz LD, Takahashi K. Abnormal differentiation of tissue macrophage populations in 'osteopetrosis' (op) mice defective in the production of macrophage colony-stimulating factor. Am J Pathol. 1991;139:657-667.
25. Felix R, Cecchini MG, Fleisch H. Macrophage colony stimulating factor restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology. 1990;127:2592-2594.
26. Kodama H, Yamasaki A, Nose M, et al. Congenital osteoclast deficiency in osteopetrotic (op/op) mice is cured by injections of macrophage colony-stimulating factor. J Exp Med. 1991;173:269-272.
27. Wiktor-Jedrzejczak W, Urbanowska E, Aukerman SL, et al. Correction by CSF-1 of defects in the osteopetrotic op/op mouse suggests local, developmental, and humoral requirements for this growth factor. Exp Hematol. 1991;19:1049-1054.
28. Ryan GR, Dai XM, Dominguez MG, et al. Rescue of the colony-stimulating factor 1 (CSF-1)-nullizygous mouse (Csf1(op)/Csf1(op)) phenotype with a CSF-1 transgene and identification of sites of local CSF-1 synthesis. Blood. 2001;98:74-84.
29. Stanley ER. The macrophage colony-stimulating factor, CSF-1. Methods Enzymol. 1985;116:564-587.
30. Stanley ER. Colony-stimulating factor (CSF) radioimmunoassay: detection of a CSF subclass stimulating macrophage production. Proc Natl Acad Sci U S A. 1979;76:2969-2973.
31. Jat PS, Sharp PA. Large T antigens of simian virus 40 and Polyomavirus efficiently establish primary fibroblasts. J Virol. 1986;59:746-775.
32. Dai XM, Zong XH, Akhter MP, Stanley ER. Osteoclast deficiency results in disorganized matrix, reduced mineralization, and abnormal osteoblast behavior in developing bone. J Bone Miner Res. 2004;19:1441-1451.
33. Luna LG. Agents and methods for specimen processing. In: Luna LG, ed. Histopathological Methods and Color Atlas of Special Stains and Tissue Artifacts. Gaithersburg, MD: American Histolabs; 1992:28-57.
34. Cole AA, Walters LM. Tartrate-resistant acid phosphatase in bone and cartilage following decalcification and cold-embedding in plastic. J Histochem Cytochem. 1987;35:203-206.
35. Kraal G, Janse M. Marginal metallophilic cells of the mouse spleen identified by a monoclonal antibody. Immunology. 1986;58:665-699.
36. Seifert MF. Abnormalities in bone cell function and endochondral ossification in the osteopetrotic toothless rat. Bone. 1996;19:329-338.
37. Hjorth-Hansen H, Seifert MF, Borset M, et al. Marked osteoblastopenia and reduced bone formation in a model of multiple myeloma bone disease in severe combined immunodeficiency mice. J Bone Miner Res. 1999;14:256-263.
38. Parfitt AM, Drezner MK, Glorieux FH, et al. Bone histomorphometry: standardization of nomenclature, symbols, and units: Report of the ASBMR Histomorphometry Nomenclature Committee. J Bone Miner Res. 1987;2:595-610.
39. Bourdon MA, Krusius T, Campbell S, Schwartz NB, Ruoslahti E. Identification and synthesis of a recognition signal for the attachment of glycosaminoglycans to proteins. Proc Natl Acad Sci U S A. 1987;84:3194-3198.
40. Price LKH. Biosynthetic studies of membrane associated and secreted L cell CSF-1. New York, NY: Albert Einstein College of Medicine of Yeshiva University; 1992.
41. Sharov AA, Weiner L, Sharova TY, et al. Noggin overexpression inhibits eyelid opening by altering epidermal apoptosis and differentiation. EMBO J. 2003;22:2992-3003.
42. Begg SK, Radley JM, Pollard JW, Chisholm OT, Stanley ER, Bertoncello I. Delayed hematopoietic development in osteopetrotic (op/op) mice. J Exp Med. 1993;177:237-242.
43. Begg SK, Bertoncello I. The hematopoietic defi-ciencies in osteopetrotic (op/op) mice are not permanent, but progressively correct with age. Exp Hematol. 1993;21:493-495.
44. Hume DA, Robinson AP, MacPherson GG, Gordon S. The mononuclear phagocyte system of the mouse defined by immunohistochemical localization of antigen F4/80: relationship between macrophages, Langerhans cells, reticular cells, and dendritic cells in lymphoid and hematopoietic organs. J Exp Med. 1983;158:1522-1536.
45. Levine JA, Jensen MD, Eberhardt NL, O'Brien T. Adipocyte macrophage colony-stimulating factor is a mediator of adipose tissue growth. J Clin Invest. 1998;101:1557-1564.
46. Weisberg SP, McCann D, Desai M, Rosenbaum M, Leibel RL, Ferrante AW Jr. Obesity is associated with macrophage accumulation in adipose tissue. J Clin Invest. 2003;112:1796-1808.
47. Broudy VC. Stem cell factor and hematopoiesis. Blood. 1997;90:1345-1364.
48. Lyman SD, Jacobsen SEW. c-kit ligand and flt3 ligand: stem/progenitor cell factors with overlapping yet distinct activities. Blood. 1998;91:1101-1134.
49. Miyazawa K, Williams DA, Gotoh A, Nishimaki J, Broxmeyer HE, Toyama K. Membrane-bound steel factor induces more persistent tyrosine kinase activation and longer life span of c-kit gene-encoded protein than its soluble form. Blood. 1995;85:641-649.
50. Yoshida H, Kunisada T, Grimm T, Nishimura EK, Nishioka E, Nishikawa SI. Review: melanocyte migration and survival controlled by SCF/c-kit expression. J Investig Dermatol Symp Proc. 2001;6:1-5.
51. Kapur R, Majumdar M, Xiao XG, McAndrews-Hill M, Schindler K, Williams DA. Signaling through the interaction of membrane-restricted stem cell factor and c-kit receptor tyrosine kinase: genetic evidence for a differential role in erythropoiesis. Blood. 1998;91:879-889.
52. Partenheimer A, Schwarz K, Wrocklage C, Kolsch E, Kresse H. Proteoglycan form of colonystimulating factor-1 (proteoglycan-100): stimulation of activity by glycosaminoglycan removal and proteolytic processing. J Immunol. 1995;155:5557-5565.
53. Suzu S, Ohtsuki T, Makishima M, et al. Biological activity of a proteoglycan form of macrophage colony-stimulating factor and its binding to type V collagen. J Biol Chem. 1992;267:16812-16815.
54. Suzu S, Inaba T, Yanai N, et al. Proteoglycan form of macrophage colony-stimulating factor binds low density lipoprotein. J Clin Invest. 1994;94:1637-1641.
55. Ohtsuki T, Hatake K, Suzu S, Saito K, Motoyoshi K, Miura Y. Immunohistochemical identification of proteoglycan form of macrophage colony-stimulating factor on bone surface. Calcif Tissue Int. 1995;57:213-217.
56. Bosse A, Kresse H, Schwarz K, Muller KM. Immunohistochemical characterization of the small proteoglycans decorin and proteoglycan-100 in heterotopic ossification. Calcif Tissue Int. 1994;54:119-124.
57. Yayon A, Klagsbrun M, Esko JD, Leder P, Ornitz DM. Cell surface, heparin-like molecules are required for binding of basic fibroblast growth factor to its high affinity receptor. Cell. 1991;64:841-848.
58. Aviezer D, Hecht D, Safran M, Eisinger M, David G, Yayon A. Perlecan, basal lamina proteoglycan, promotes basic fibroblast growth factor-receptor binding, mitogenesis, and angiogenesis. Cell. 1994;79:1005-1013.
59. Partridge EA, Le Roy C, Di Guglielmo GM, et al. Regulation of cytokine receptors by Golgi N-glycan processing and endocytosis. Science. 2004;306:120-124.
60. Suzu S, Kimura F, Yamada M, et al. Direct interaction of proteoglycan macrophage colonystimulating factor and basic fibroblast growth factor. Blood. 1994;83:3113-3119.
61. Rajavashisth T, Qiao JH, Tripathi S, et al. Heterozygous osteopetrotic (op) mutation reduces atherosclerosis in LDL receptor-deficient mice. J Clin Invest. 1998;101:2702-2710.
62. Campbell IK, Rich MJ, Bischof RJ, Hamilton JA. The colony-stimulating factors and collageninduced arthritis: exacerbation of disease by M-CSF and G-CSF and requirement for endogenous M-CSF. J Leukoc Biol. 2000;68:144-150.
63. Lenda DM, Kikawada E, Stanley ER, Kelley VR. Reduced macrophage recruitment, proliferation, and activation in colony-stimulating factor-1-deficient mice results in decreased tubular apoptosis during renal inflammation. J Immunol. 2003;170:3254-3262.
64. Lin EY, Nguyen AV, Russell RG, Pollard JW. Colony-stimulating factor 1 promotes progression of mammary tumors to malignancy. J Exp Med. 2001;193:727-740.
65. Aharinejad S, Abraham D, Paulus P, et al. Colony-stimulating factor-1 antisense treatment suppresses growth of human tumor xenografts in mice. Cancer Res. 2002;62:5317-5324.
66. Aharinejad S, Paulus P, Sioud M, et al. Colonystimulating factor-1 blockade by antisense oligonucleotides and small interfering RNAs suppresses growth of human mammary tumor xenografts in mice. Cancer Res. 2004;64:5378-5384.
67. The Jackson Laboratory. Mouse nomenclature rules and guidelines. http://jaxmice.jax.org/ request/nomenclature.html. Accessed May 1, 2005.